Prima BioMed Announces Immutep's IMP321 Patent Application Receives Canadian Patent Office Notice of Grant
December 22, 2014 07:10 ET
|
Prima Biomed
SYDNEY, AUSTRALIA--(Marketwired - Dec 22, 2014) - Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company") is pleased to announce that it has received a Notice of Grant from the Canadian...
Prima BioMed Completes Immutep Acquisition
December 17, 2014 08:23 ET
|
Prima Biomed
SYDNEY, AUSTRALIA--(Marketwired - Dec 17, 2014) - Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima" or the "Company") announces that the acquisition of Immutep SA ("Immutep"), the French...
Prima Biomed Enhances CVac Manufacturing and Logistics Capability
December 05, 2014 07:55 ET
|
Prima Biomed
SYDNEY, AUSTRALIA--(Marketwired - Dec 5, 2014) - Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company") announces several enhancements to its CVac manufacturing and logistics...
CVac Demonstrates Overall Survival Benefit in Second Remission Ovarian Cancer
November 06, 2014 07:45 ET
|
Prima Biomed
SYDNEY, AUSTRALIA--(Marketwired - Nov 6, 2014) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)
Overall Survival data from the CAN-003 trial continues to show benefit for...
Prima BioMed to Host Conference Call & Webcast to Discuss Acquisition of Immutep
October 21, 2014 11:14 ET
|
Prima BioMed
SYDNEY, AUSTRALIA--(Marketwired - Oct 21, 2014) - Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima" or "the Company") advises that the Company will host a shareholder conference call and...
Prima Announces Immutep's IMP321 Patent Application Receives Australian Notice of Allowance
October 14, 2014 08:44 ET
|
PrimaBiomed
SYDNEY, AUSTRALIA--(Marketwired - Oct 14, 2014) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") is pleased to announce that Immutep S.A. ("Immutep") has received a Notice of...
Prima Secures US$37.4M Investment Agreement With US Institutional Investor Bergen
October 02, 2014 07:00 ET
|
Prima BioMed Ltd
SYDNEY, AUSTRALIA--(Marketwired - Oct 2, 2014) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)
Highlights
Investment agreement for up to US$37.4 million to fund...
Prima BioMed Announces Strategic Acquisition of Immutep SA
October 02, 2014 07:00 ET
|
Prima BioMed Ltd
SYDNEY, AUSTRALIA--(Marketwired - Oct 2, 2014) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD)
Highlights
Prima to acquire French biopharmaceutical company...
Prima Receives US Patent Grant for CVac
July 16, 2014 08:19 ET
|
Prima BioMed
SYDNEY, AUSTRALIA--(Marketwired - Jul 16, 2014) - Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") announces that the US patent number 8,771,701 titled "Compositions for...
Prima BioMed Appoints New Chief Executive Officer
July 09, 2014 03:55 ET
|
Prima BioMed Ltd
SYDNEY, AUSTRALIA--(Marketwired - Jul 9, 2014) - The Board of Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", "the Company") announces that Marc Voigt has today been appointed as Chief...